濟民健康(603222.SH):副總裁涉嫌犯罪及公司報案並收到立案通知書
格隆匯3月26日丨濟民健康(603222.SH)公佈,近期,公司陸續收到部分經銷商發送的律師函,稱除與公司簽署《經銷協議》外,還與公司簽署了《補充協議》,要求公司按照《補充協議》約定履行退貨退款義務,並支付貨款資金佔用補償。公司收到上述律師函後,立即啓動了相關事項調查。
經調查發現,公司副總裁何清紅及其團隊成員於2023年3月私刻了公司及其子公司(聚民生物科技有限公司、浙江濟民堂醫藥貿易有限公司)的印章,並在銷售過程中,冒用公司名義用假章與經銷商簽署《補充協議》,約定若經銷商在一定期限內(如3個月、6個月)沒有實現產品銷售,在不影響二次銷售的情況下,有權退回公司,公司需給予經銷商所退回產品採購金額10%的資金佔用補償(一般爲10%)。
何清紅及其團隊成員上述行爲涉嫌僞造公司印章罪。公司取得初步證據後,於2025年3月24日向臺州市公安局黃巖分局報案,並於2025年3月26日收到臺州市公安局黃巖分局出具的《立案告知書》,主要內容爲:臺州市公安局黃巖分局認爲公司報稱的“何清紅等人僞造公司印章”一案,符合刑事立案標準,現已對該案立案偵查。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.